Mahvash disease (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mahvash disease" in English language version.

refsWebsite

Global rank English rank

18nih.gov

4^th place

12doi.org

2^nd place

1omim.org

4,380^th place

4,305^th place

1semanticscholar.org

11^th place

8^th place

1harvard.edu

18^th place

17^th place

doi.org

Yu R (2018). "Mahvash Disease: 10 Years After Discovery". Pancreas. 47 (5): 511–515. doi:10.1097/MPA.0000000000001044. PMID 29702528. S2CID 13871451.
Zhou C, Dhall D, Nissen NN, Chen CR, Yu R (November 2009). "Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor". Pancreas. 38 (8): 941–6. doi:10.1097/MPA.0b013e3181b2bb03. PMC 2767399. PMID 19657311.
Sipos B, Sperveslage J, Anlauf M, Hoffmeister M, Henopp T, Buch S, Hampe J, Weber A, Hammel P, Couvelard A, Höbling W, Lieb W, Boehm BO, Klöppel G (May 2015). "Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations". The Journal of Clinical Endocrinology and Metabolism. 100 (5): E783-8. doi:10.1210/jc.2014-4405. PMID 25695890.
Larger E, Wewer Albrechtsen NJ, Hansen LH, Gelling RW, Capeau J, Deacon CF, Madsen OD, Yakushiji F, De Meyts P, Holst JJ, Nishimura E (2016). "Pancreatic α-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation". Endocrinology, Diabetes & Metabolism Case Reports. 2016: 0081. doi:10.1530/EDM-16-0081. PMC 5118975. PMID 27933176.
Gild ML, Tsang V, Samra J, Clifton-Bligh RJ, Tacon L, Gill AJ (September 2018). "Hypercalcemia in Glucagon Cell Hyperplasia and Neoplasia (Mahvash Syndrome): A New Association". The Journal of Clinical Endocrinology and Metabolism. 103 (9): 3119–3123. doi:10.1210/jc.2018-01074. PMID 30032256.
Li H, Zhao L, Singh R, Ham JN, Fadoju DO, Bean LJ, Zhang Y, Xu Y, Xu HE, Gambello MJ (December 2018). "GCGR is identified by newborn screening of elevated arginine". Molecular Genetics and Metabolism Reports. 17: 46–52. doi:10.1016/j.ymgmr.2018.09.006. PMC 6171159. PMID 30294546.
Amano S, Suenaga S, Hamamoto K, Yada S, Tsuyama T, Shinoda S, Tanaka Y, Takemoto Y, Harada E, Tanabe K, Asahara S, Hoshii K, Takami T (March 2023). "A case of multiple glucagonomas with no clinical manifestations of excess glucagon despite hyperglucagonemia". DEN Open. 3 (1): e230. doi:10.1002/deo2.230. PMC 10043567. PMID 36998346.
Deng W, He M, Wang W, Xue H (August 2023). "Gastrointestinal: Pancreatic NETs with GCGR heterozygous mutation: Mahvash disease". J Gastroenterol Hepatol. 38 (8): 1243. doi:10.1111/jgh.16104. PMID 36698259.
Robbins J, Halegoua-DeMarzio D, Basu Mallick A, Vijayvergia N, Ganetzky R, Lavu H, Giri VN, Miller J, Maley W, Shah AP, DiMeglio M, Ambelil M, Yu R, Sato T, Lefler DS (November 2023). "Liver transplantation in a woman with Mahvash disease". New England Journal of Medicine. 389 (21): 1972–8. doi:10.1056/NEJMoa2303226. PMID 37991855.
Yu R (March 2014). "Pancreatic α-cell hyperplasia: facts and myths". The Journal of Clinical Endocrinology and Metabolism. 99 (3): 748–56. doi:10.1210/jc.2013-2952. PMID 24285676.
Solloway MJ, Madjidi A, Gu C, Eastham-Anderson J, Clarke HJ, Kljavin N, et al. (July 2015). "Glucagon Couples Hepatic Amino Acid Catabolism to mTOR-Dependent Regulation of α-Cell Mass". Cell Reports. 12 (3): 495–510. doi:10.1016/j.celrep.2015.06.034. PMID 26166562.
Yu R, Dhall D, Nissen NN, Zhou C, Ren SG (2011). "Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice". PLOS ONE. 6 (8): e23397. Bibcode:2011PLoSO...623397Y. doi:10.1371/journal.pone.0023397. PMC 3154424. PMID 21853126.

harvard.edu

ui.adsabs.harvard.edu

Yu R, Dhall D, Nissen NN, Zhou C, Ren SG (2011). "Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice". PLOS ONE. 6 (8): e23397. Bibcode:2011PLoSO...623397Y. doi:10.1371/journal.pone.0023397. PMC 3154424. PMID 21853126.

nih.gov

pubmed.ncbi.nlm.nih.gov

Yu R (2018). "Mahvash Disease: 10 Years After Discovery". Pancreas. 47 (5): 511–515. doi:10.1097/MPA.0000000000001044. PMID 29702528. S2CID 13871451.
Zhou C, Dhall D, Nissen NN, Chen CR, Yu R (November 2009). "Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor". Pancreas. 38 (8): 941–6. doi:10.1097/MPA.0b013e3181b2bb03. PMC 2767399. PMID 19657311.
Sipos B, Sperveslage J, Anlauf M, Hoffmeister M, Henopp T, Buch S, Hampe J, Weber A, Hammel P, Couvelard A, Höbling W, Lieb W, Boehm BO, Klöppel G (May 2015). "Glucagon cell hyperplasia and neoplasia with and without glucagon receptor mutations". The Journal of Clinical Endocrinology and Metabolism. 100 (5): E783-8. doi:10.1210/jc.2014-4405. PMID 25695890.
Larger E, Wewer Albrechtsen NJ, Hansen LH, Gelling RW, Capeau J, Deacon CF, Madsen OD, Yakushiji F, De Meyts P, Holst JJ, Nishimura E (2016). "Pancreatic α-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation". Endocrinology, Diabetes & Metabolism Case Reports. 2016: 0081. doi:10.1530/EDM-16-0081. PMC 5118975. PMID 27933176.
Gild ML, Tsang V, Samra J, Clifton-Bligh RJ, Tacon L, Gill AJ (September 2018). "Hypercalcemia in Glucagon Cell Hyperplasia and Neoplasia (Mahvash Syndrome): A New Association". The Journal of Clinical Endocrinology and Metabolism. 103 (9): 3119–3123. doi:10.1210/jc.2018-01074. PMID 30032256.
Li H, Zhao L, Singh R, Ham JN, Fadoju DO, Bean LJ, Zhang Y, Xu Y, Xu HE, Gambello MJ (December 2018). "GCGR is identified by newborn screening of elevated arginine". Molecular Genetics and Metabolism Reports. 17: 46–52. doi:10.1016/j.ymgmr.2018.09.006. PMC 6171159. PMID 30294546.
Amano S, Suenaga S, Hamamoto K, Yada S, Tsuyama T, Shinoda S, Tanaka Y, Takemoto Y, Harada E, Tanabe K, Asahara S, Hoshii K, Takami T (March 2023). "A case of multiple glucagonomas with no clinical manifestations of excess glucagon despite hyperglucagonemia". DEN Open. 3 (1): e230. doi:10.1002/deo2.230. PMC 10043567. PMID 36998346.
Deng W, He M, Wang W, Xue H (August 2023). "Gastrointestinal: Pancreatic NETs with GCGR heterozygous mutation: Mahvash disease". J Gastroenterol Hepatol. 38 (8): 1243. doi:10.1111/jgh.16104. PMID 36698259.
Robbins J, Halegoua-DeMarzio D, Basu Mallick A, Vijayvergia N, Ganetzky R, Lavu H, Giri VN, Miller J, Maley W, Shah AP, DiMeglio M, Ambelil M, Yu R, Sato T, Lefler DS (November 2023). "Liver transplantation in a woman with Mahvash disease". New England Journal of Medicine. 389 (21): 1972–8. doi:10.1056/NEJMoa2303226. PMID 37991855.
Yu R (March 2014). "Pancreatic α-cell hyperplasia: facts and myths". The Journal of Clinical Endocrinology and Metabolism. 99 (3): 748–56. doi:10.1210/jc.2013-2952. PMID 24285676.
Solloway MJ, Madjidi A, Gu C, Eastham-Anderson J, Clarke HJ, Kljavin N, et al. (July 2015). "Glucagon Couples Hepatic Amino Acid Catabolism to mTOR-Dependent Regulation of α-Cell Mass". Cell Reports. 12 (3): 495–510. doi:10.1016/j.celrep.2015.06.034. PMID 26166562.
Yu R, Dhall D, Nissen NN, Zhou C, Ren SG (2011). "Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice". PLOS ONE. 6 (8): e23397. Bibcode:2011PLoSO...623397Y. doi:10.1371/journal.pone.0023397. PMC 3154424. PMID 21853126.

ncbi.nlm.nih.gov

Zhou C, Dhall D, Nissen NN, Chen CR, Yu R (November 2009). "Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor". Pancreas. 38 (8): 941–6. doi:10.1097/MPA.0b013e3181b2bb03. PMC 2767399. PMID 19657311.
Larger E, Wewer Albrechtsen NJ, Hansen LH, Gelling RW, Capeau J, Deacon CF, Madsen OD, Yakushiji F, De Meyts P, Holst JJ, Nishimura E (2016). "Pancreatic α-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation". Endocrinology, Diabetes & Metabolism Case Reports. 2016: 0081. doi:10.1530/EDM-16-0081. PMC 5118975. PMID 27933176.
Li H, Zhao L, Singh R, Ham JN, Fadoju DO, Bean LJ, Zhang Y, Xu Y, Xu HE, Gambello MJ (December 2018). "GCGR is identified by newborn screening of elevated arginine". Molecular Genetics and Metabolism Reports. 17: 46–52. doi:10.1016/j.ymgmr.2018.09.006. PMC 6171159. PMID 30294546.
Amano S, Suenaga S, Hamamoto K, Yada S, Tsuyama T, Shinoda S, Tanaka Y, Takemoto Y, Harada E, Tanabe K, Asahara S, Hoshii K, Takami T (March 2023). "A case of multiple glucagonomas with no clinical manifestations of excess glucagon despite hyperglucagonemia". DEN Open. 3 (1): e230. doi:10.1002/deo2.230. PMC 10043567. PMID 36998346.
Yu R, Dhall D, Nissen NN, Zhou C, Ren SG (2011). "Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice". PLOS ONE. 6 (8): e23397. Bibcode:2011PLoSO...623397Y. doi:10.1371/journal.pone.0023397. PMC 3154424. PMID 21853126.

rarediseases.info.nih.gov

"Mahvash disease, Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. National Institutes of Health. Retrieved 2018-12-08.

omim.org

"MAHVASH DISEASE; MVAH, Online Mendelian Inheritance in Man (OMIM)". www.omim.org. Johns Hopkins University. Retrieved 2023-11-23.

semanticscholar.org

api.semanticscholar.org

Yu R (2018). "Mahvash Disease: 10 Years After Discovery". Pancreas. 47 (5): 511–515. doi:10.1097/MPA.0000000000001044. PMID 29702528. S2CID 13871451.